about us


 

GLS Pharma is an established, professionally managed pharmaceutical company launched by technocrats with extensive experience in the field of drugs & pharmaceuticals with an absolute focus on product quality and customer services.

Within GLS, we are augmenting the value chain through total backward integration. We make 38 oncology APIs in our group company Vibgyor Drug Limited. Thus GLS controls the cost without compromising the quality.

our latest introductions


MELFALAX INJECTION

Melphalan is an indispensable part of Multiple Myeloma treatment. Being available in oral dosage form, it adds to the convenience of the patient, especially in ‘all oral’ chemotherapy regimens.

CARNUMAX

A cell-cycle phase nonspecific alkylating antineoplastic agent. It is a nitrogen mustard β-chloro-nitrosourea compound. It is used in the treatment of brain tumors and various other malignant neoplasms, Multiple myeloma, Hodgkin’s and Non-Hodgkin’s lymphoma.

PROLEMAX

Leuprolide acetate is a gonadotropin-releasing hormone (GnRH) agonist. Leuprolide acetate is approved for palliative treatment of advanced Prostate cancer.

BENDAMAX

Bendamustine hydrochloride is a bifunctional chemotherapeutic agent with structurally similar to alkylating agents and purine analogues.

BUSULMAX

Busulfan is a bifunctional alkylating agent, having a selective immunosuppressive effect on bone marrow. It has been used in the palliative treatment of Chronic Myeloid Leukemia (CML).

FLUDAMAX

Fludarabine is a purine analogue that has replaced traditional alkylating agent based standard initial treatment of Chronic Lymphocytic Leukemia (CLL)